Stock Track | Calumet Specialty Products Plunges 5.50% Pre-market on Wider Q2 Loss, EPS Miss

Stock Track
Aug 08, 2025

Calumet Specialty Products Partners LP (CLMT) saw its stock plummet 5.50% in pre-market trading on Friday following the release of its second-quarter 2025 financial results. The company reported a significant widening of its net loss and a substantial earnings per share (EPS) miss, overshadowing positive revenue performance.

The specialty hydrocarbon and fuel products company reported a Q2 net loss of $147.9 million, or $1.70 per diluted share, compared to a loss of $39.1 million, or $0.48 per share, in the same period last year. This result fell far short of analyst expectations, with FactSet's consensus estimate projecting a loss of only $0.34 per share. The wider loss came despite Calumet's efforts to reduce costs, having achieved $42 million in year-over-year operating cost savings through the first half of 2025.

On a more positive note, Calumet's Q2 revenue of $1.03 billion surpassed analyst expectations of $925.2 million. The company also reported an increase in Adjusted EBITDA with Tax Attributes to $76.5 million, up from $74.8 million in the previous year. However, these positives were not enough to offset investor concerns about the significant bottom-line deterioration. The pre-market plunge suggests that market participants are focusing on the company's profitability challenges rather than its top-line performance and cost-saving initiatives.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10